Literature DB >> 16697362

Biological and clinical aspects of the vitamin D binding protein (Gc-globulin) and its polymorphism.

Marijn Speeckaert1, Guangming Huang, Joris R Delanghe, Youri E C Taes.   

Abstract

The vitamin D binding protein (DBP) is the major plasma carrier protein of vitamin D and its metabolites. Unlike other hydrophobic hormone-binding systems, it circulates in a considerably higher titer compared to its ligands. Apart from its specific sterol binding capacity, DBP exerts several other important biological functions such as actin scavenging, fatty acid transport, macrophage activation and chemotaxis. The DBP-gene is a member of a multigene cluster that includes albumin, alpha-fetoprotein, and alpha-albumin/afamin. All four genes are expressed predominantly in the liver with overlapping developmental profiles. DBP is a highly polymorphic serum protein with three common alleles (Gc1F, Gc1S and Gc2) and more than 120 rare variants. The presence of unique alleles is a useful tool for anthropological studies to discriminate and to reveal ancestral links between populations. Many studies have discussed the link between DBP-phenotypes and susceptibility or resistance to osteoporosis, Graves' disease, Hashimoto's thyroiditis, diabetes, COPD, AIDS, multiple sclerosis, sarcoidosis and rheumatic fever. This article reviews the general characteristics, functions and clinical aspects of DBP.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16697362     DOI: 10.1016/j.cca.2006.03.011

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  178 in total

1.  Polymorphic variation in the GC and CASR genes and associations with vitamin D metabolite concentration and metachronous colorectal neoplasia.

Authors:  Elizabeth A Hibler; Chengcheng Hu; Peter W Jurutka; Maria E Martinez; Elizabeth T Jacobs
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-12-05       Impact factor: 4.254

2.  Heritability and seasonal variability of vitamin D concentrations in male twins.

Authors:  Cristina Karohl; Shaoyong Su; Meena Kumari; Vin Tangpricha; Emir Veledar; Viola Vaccarino; Paolo Raggi
Journal:  Am J Clin Nutr       Date:  2010-10-13       Impact factor: 7.045

3.  Serum 25-hydroxyvitamin D, vitamin D binding protein and risk of colorectal cancer in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.

Authors:  Stephanie J Weinstein; Mark P Purdue; Stephanie A Smith-Warner; Alison M Mondul; Amanda Black; Jiyoung Ahn; Wen-Yi Huang; Ronald L Horst; William Kopp; Helen Rager; Regina G Ziegler; Demetrius Albanes
Journal:  Int J Cancer       Date:  2014-09-02       Impact factor: 7.396

Review 4.  New vitamin D analogs as potential therapeutics in melanoma.

Authors:  Paulina Szyszka; Michal A Zmijewski; Andrzej T Slominski
Journal:  Expert Rev Anticancer Ther       Date:  2012-05       Impact factor: 4.512

5.  Population studies of intact vitamin D binding protein by affinity capture ESI-TOF-MS.

Authors:  Chad R Borges; Jason W Jarvis; Paul E Oran; Stephen P Rogers; Randall W Nelson
Journal:  J Biomol Tech       Date:  2008-07

6.  Functional status and inflammation after preseason training program in professional and recreational soccer players: a proteomic approach.

Authors:  Francisco J Martín-Sánchez; José María Villalón; José J Zamorano-León; Luis Fernández Rosas; Ricardo Proietti; Petra J Mateos-Caceres; Juan J González-Armengol; Pedro Villarroel; Carlos Macaya; Antonio J López-Farré
Journal:  J Sports Sci Med       Date:  2011-03-01       Impact factor: 2.988

7.  Vitamin D-Binding Protein and Risk of Renal Cell Carcinoma in the Cancer Prevention Study-II Cohort.

Authors:  Marjorie L McCullough; Demetrius Albanes; Alison M Mondul; Stephanie J Weinstein; Dominick Parisi; Caroline Y Um
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2018-07-20       Impact factor: 4.254

8.  Vitamin D binding protein gene polymorphisms and chronic obstructive pulmonary disease: a meta-analysis.

Authors:  Huan Chen; Lei Zhang; Zhiyi He; Xiaoning Zhong; Jianquan Zhang; Meihua Li; Jing Bai
Journal:  J Thorac Dis       Date:  2015-08       Impact factor: 2.895

9.  Vitamin D-binding protein, circulating vitamin D and risk of renal cell carcinoma.

Authors:  Alison M Mondul; Stephanie J Weinstein; Kristin A Moy; Satu Männistö; Demetrius Albanes
Journal:  Int J Cancer       Date:  2014-01-30       Impact factor: 7.396

10.  Vitamin D-binding protein interacts with Aβ and suppresses Aβ-mediated pathology.

Authors:  M Moon; H Song; H J Hong; D W Nam; M-Y Cha; M S Oh; J Yu; H Ryu; I Mook-Jung
Journal:  Cell Death Differ       Date:  2012-12-21       Impact factor: 15.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.